Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma
Tumor lysis syndrome (TLS) is a severe metabolic complication that usually occurs in patients with aggressive tumors who undergo treatment with chemotherapy. Traditionally, it was mainly associated with hematologic malignancies. However, over the past 4 decades, there have been increasing reports of...
Main Authors: | Prasanth Lingamaneni MD, Parth Desai MD, Madhu Mathew Vennikandam MD, Krishna Moturi MD, Anmol Baranwal MD, Shweta Gupta MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709620933427 |
Similar Items
-
Tumor Lysis Syndrome in a Retroperitoneal Sarcoma
by: Yousef Zakharia MD, et al.
Published: (2014-07-01) -
Merkel Cell Carcinoma With Isolated Pancreatic Metastasis
by: Prasanth Lingamaneni MD, et al.
Published: (2021-06-01) -
Spontaneous Tumor Lysis Syndrome
by: Alicia C. Weeks MD, et al.
Published: (2015-08-01) -
Heparin-Induced Thrombocytopenia in COVID-19
by: Prasanth Lingamaneni MD, et al.
Published: (2020-07-01) -
Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma
by: Robin Moiseff, et al.
Published: (2021-01-01)